Ophthalmic Femtosecond Lasers Market Size, Share and Global Trend By Product (Equipment, Consumables and accessories), By Application (Refractive Surgery, Cataract Surgery, Keratoplasty, Pocket Creation, Intracorneal Rings, Incisions & Flap Cuts), By Type of Cells (Hospitals, Speciality Clinics, Ambulatory Surgical Centers, Eye Institutes) and Regional Forecast, 2024-2032

With the introduction of laser technology for eye surgery and the technological enhancement for better results, the eye care market has witnessed a remarkable upsurge during the past decade. The global burden of vision impairment and eye disorders is now being addressed by the latest technological interventions such as ophthalmic femtosecond lasers.

According to the ASCRS Clinical Survey in 2016, an estimated three-fourths of eye surgeons are using femtosecond lasers for the creation of LASIK flaps in the U.S. Characteristics of the femtosecond wavelength and capacity to perform multiple geometrical cuts permit the use of ophthalmic femtosecond lasers in various ophthalmic surgeries. Moreover, ophthalmic femtosecond lasers work with comparatively reduced trauma to the tissues, resulting in less inflammation as well as an early recovery.

The global ophthalmic femtosecond lasers market is witnessing frequent new product launches and technological enhancements to improve and expand the capabilities of ophthalmic femtosecond lasers such as the inclusion of lenticule extraction capabilities for femtosecond laser system LDV Z8 by Ziemer Ophthalmic Systems in 2018.

The growth in the global ophthalmic femtosecond lasers market is mainly driven by the increasing prevalence of eye diseases. Moreover, the technological advancements in the ophthalmic femtosecond lasers are also expected to drive the growth in the global ophthalmic femtosecond lasers market.

For example, in 2018, Alcon, a division of Novartis AG and one of the considerable player in eye care solutions, launched a technological enhancement in its ophthalmic femtosecond lasers product LanSx, that can be used to treat intracorneal rings and pockets for presbyopia-correcting inlays.

However, increased risk of complications such as pupillary constriction, capsular block syndrome and the prominent position of phacoemulsification for cataract surgery are the factors that may hinder the growth in global ophthalmic femtosecond lasers market.

Key Players Covered

Some of the major companies that are present in the global ophthalmic femtosecond lasers market are Johnson & Johnson Surgical Vision Inc., Bausch & Lomb Incorporated, LENSAR Inc., Carl Zeiss Meditec AG, Novartis AG (Alcon), Ziemer Ophthalmic Systems, Abbott, IMRA America, Inc., KMLABS, Menlo Systems, and other players.

SEGMENTATION

Owing to the number of cataract surgery performed worldwide and rising prevalence of diabetes, cataract surgery segment is estimated to witness significant growth in the global ophthalmic femtosecond lasers market during the forecast period. According to the American Academy of Ophthalmology, 50 million people are projected to have a cataract in the U.S. by 2050, which is likely to fuel the global ophthalmic femtosecond lasers market.

Key Insights

• Regulatory scenario for key countries


• Recent industry developments such as partnerships, mergers, and acquisitions


• Prevalence of Eye Diseases – For Key Countries


• Number of Ophthalmic Surgery – For Key Countries

Regional Analysis

The global ophthalmic femtosecond lasers market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In North America, the global ophthalmic femtosecond lasers market is anticipated to grow in the forecast period due to the increasing number of patients undergoing cataract surgery and the technological advancements in femtosecond lasers. According to the American Academy of Ophthalmology, an estimated 2 million cataract surgeries are performed each year in the U.S., this makes North America as a flourishing regional segment in global ophthalmic femtosecond lasers market. In Asia Pacific, the global ophthalmic femtosecond lasers market is projected to expand owing to the rising number of ENT clinics and developing health infrastructure.

Key Industry Developments

• In April 2018, Alcon, a division of Novartis AG introduced technological enhancements in its ophthalmic femtosecond lasers product LanSx so that it can be used for two more disease indications namely, intracorneal rings and pockets for presbyopia-correcting inlays.
• In February 2018, LENSAR Inc., one of the leaders in femtosecond laser technology acquired Precision Eye Services (PES) Inc. laser business unit.
• In April 2018, LENSAR Inc., received FDA clearance for the company’s femtosecond laser LENSAR Laser System with Streamline IV, to include creation of flaps and corneal pockets.
• In September 2018, Ziemer Ophthalmic Systems announced inclusion of lenticule extraction capabilities for the company femtosecond laser system LDV Z8.